However, elevated EZH2 expression has also been reported in AML patients52,53, and dual inhibition of EZH1/2 was found to eliminate quiescent leukaemic stem cells (LSCs) to prevent relapse25. The gene discussed is EZH2; the disease is acute myeloid leukemia.